Strengthening pharmacovigilance and regulatory capacity in Southern Africa (SPaRCS): achievements, experiences and lessons learned from a participatory action learning project
Frontiers in Drug Safety and Regulation · 29.05.2026 · 6
DOI: 10.3389/fdsfr.2026.1765077 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Drug Safety and Regulation, online erschienen am 29.05.2026. Verfasst von Michelle Viljoen und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of the Western Cape, Cape Town, South Africa. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European and Developing Countries Clinical Trials Partnership.
Abstract (Originalsprache)
Effective regulatory systems play a critical role in improving access to safe, efficacious and quality medicines and vaccines. However, most regulatory and pharmacovigilance (PV) systems in sub-Saharan Africa (SSA) are still under-resourced and lack recognition of their public health service role, despite encouraging developments in several countries, and positive experiences of harmonization across the continent. The aim of Strengthening pharmacovigilance and regulatory capacities in four Southern African countries (SPaRCS), was to improve pharmacovigilance and clinical trials oversight in Namibia, Eswatini, Zimbabwe and South Africa. The project used a participatory action learning and co-creation approach and built on existing relationships with national regulatory authorities and PV centres in the four countries. Key activities included a mapping of PV and clinical trials oversight in the four partner countries; participatory workshops and learning exchanges in two thematic areas; Strengthening PV systems and Clinical trials oversight, and collaborative development of a training package for community health workers on adverse drug reaction reporting. Intentionally SPaRCS provided opportunities for partners in the four countries to develop relationships amongst those involved in PV and clinical trials oversight in the region. This included sharing of challenges, field experiences and best practices in a sub-national, national and regional setting. Strong commitment of country partners and the flexible learning and co-creation approach facilitated positive achievements. Strengthening PV and clinical trial oversight requires a multi-faceted approach involving the establishment of robust systems, addressing infrastructure and training gaps, integrating PV into public health programs and building formal collaborative platforms at regional level. The regional platform created by SPaRCS provided a starting point, for the establishment of the Centre of Excellence for Pharmacovigilance in Southern Africa (CEPSA) launched at the end of 2024.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, University of the Western Cape, Cape Town, South Africa.
- Pharmacovigilance Centre for Public Health Programs, National Department of Health, Pretoria, South Africa.
- Pharmacovigilance and Clinical Trials Division, Medicines Control Authority of Zimbabwe, Harare, Zimbabwe.
- Namibia Medicines Regulatory Council, Ministry of Health and Social Services, Windhoek, Namibia.
- Pharmaceutical Services, Ministry of Health, Mbabane, Eswatini.
- Independent Consultant, Barcelona, Spain.
Förderung
- European and Developing Countries Clinical Trials Partnership
Zitieren
APA
Viljoen, M., Khoza, S., Dheda, M., Chirinda, L., Shigwedha, F., Shimbulu, A., Nhlabatsi, S., Shongwe, N., Figueras, A., Ravinetto, R., & Bradley, H. (2026). Strengthening pharmacovigilance and regulatory capacity in Southern Africa (SPaRCS): achievements, experiences and lessons learned from a participatory action learning project. Frontiers in Drug Safety and Regulation, 6. https://doi.org/10.3389/fdsfr.2026.1765077
Vancouver
Viljoen M, Khoza S, Dheda M, Chirinda L, Shigwedha F, Shimbulu A, et al. Strengthening pharmacovigilance and regulatory capacity in Southern Africa (SPaRCS): achievements, experiences and lessons learned from a participatory action learning project. Frontiers in Drug Safety and Regulation. 2026;6. doi:10.3389/fdsfr.2026.1765077
BibTeX
@article{Viljoen2026,
author = {Viljoen, Michelle and Khoza, Star and Dheda, Mukesh and Chirinda, Libert and Shigwedha, Frieda and Shimbulu, Anna and Nhlabatsi, SipheSihle and Shongwe, Nomsa and Figueras, Albert and Ravinetto, Raffaella and Bradley, Hazel},
title = {Strengthening pharmacovigilance and regulatory capacity in Southern Africa (SPaRCS): achievements, experiences and lessons learned from a participatory action learning project},
journal = {Frontiers in Drug Safety and Regulation},
year = {2026},
volume = {6},
doi = {10.3389/fdsfr.2026.1765077}
}
EUVIMED